SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-167282
Filing Date
2009-08-06
Accepted
2009-08-06 16:44:07
Documents
6
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 508695
2 AMENDMENT NO. 4 TO THE EXCLUSIVE LICENSE AGREEMENT dex1042.htm EX-10.42 36062
3 CERTIFICATION OF CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 10361
4 CERTIFICATION OF CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 10073
5 CERTIFICATION OF CEO PURSUANT TO SECTION 906 dex321.htm EX-32.1 4956
6 CERTIFICATION OF CFO PURSUANT TO SECTION 906 dex322.htm EX-32.2 4852
  Complete submission text file 0001193125-09-167282.txt   576429
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34207 | Film No.: 09992214
SIC: 2834 Pharmaceutical Preparations